Samuel Denmeade, MD
Johns Hopkins University · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · SKCCC at Johns Hopkins
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Samuel Denmeade, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07142551 · Supraphysiologic Testosterone Priming Induces Darolutamide Extended ResponseSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT06922318 · The COSMYC Trial (COmbined Suppression of MYC)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT05081193 · Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT04363164 · Sequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · Castration Resistant Metastatic Prostate Cancer · principal investigator
- Ph1NCT02995330 · Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Prostate Cancer · principal investigator
- Ph2NCT02286921 · Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide ResistanceSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Castration Resistant Metastatic Prostate Cancer · principal investigator
- Ph2NCT02090114 · RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Prostate Cancer · principal investigator
- Ph1NCT01983709 · Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Prostate Cancer · principal investigator
- Ph2NCT01750398 · Bipolar Androgen-based Therapy for Prostate Cancer (BAT)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Recurrent Prostate Cancer · principal investigator
- N/ANCT01084759 · A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 1: Combined Suppression of MYC as therapy for CRPC: the COSMYC trialP50CA272391 · NCI · JOHNS HOPKINS UNIVERSITY · PI Samuel R Denmeade · fiscal years 2024 to 2026Named on NCT06922318
- Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate CancerR01CA184012 · NCI · JOHNS HOPKINS UNIVERSITY · PI Samuel R Denmeade · fiscal years 2014 to 2018Named on NCT02090114
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.